EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 59 filers reported holding EIDOS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $18,000 | – | 1,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $55,047,000 | 23.98% |
| Opaleye Management Inc. | 315,550 | $15,459,000 | 4.10% |
| RA Capital Management | 2,162,671 | $105,949,000 | 3.35% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,015,000 | 2.63% |
| Cormorant Asset Management, LP | 1,100,000 | $53,889,000 | 2.50% |
| Parkman Healthcare Partners LLC | 81,085 | $3,972,000 | 1.84% |
| EAM Global Investors LLC | 38,535 | $1,888,000 | 1.10% |
| Redmile Group, LLC | 689,478 | $33,778,000 | 0.95% |
| Perceptive Advisors | 686,922 | $33,652,000 | 0.88% |
| EAM Investors, LLC | 55,532 | $2,721,000 | 0.84% |